Custom service
Peptide Drug Gene Construction and Expression Platform
Construct and express genes for peptide-drug screening scaffolds
Teams come to this service when they need to construct and express genes for peptide-drug screening scaffolds. We typically start from gene synthesis and vector design, add expression construct optimization where the application demands it, and close the loop with display-format compatibility so the final expression constructs and validated expression data behaves consistently across lots.
Design reviews are part of the schedule, not an extra. Sequence, spacer architecture and analytical strategy are signed off before the first synthesis run, which is why the 4–8 weeks timeline holds in practice.
Display-library gene preparation
Recombinant scaffold supply for screening
GMP gene-drug product
Targets with no assayable readout and no purified protein available
Screening programmes close with a data package: primary screen statistics, confirmation data for each hit, counterscreen results and resynthesized material. Library lots ship with composition QC — representation and identity checks by LC-MS or NGS as the format requires.
Service Highlights
- Gene synthesis and vector design as the default route, with expression construct optimization held as a proven fallback
- Display-format compatibility worked into the design where the application requires it
- Every reported hit is confirmed by independent resynthesis and re-testing before it reaches you
- Analytical confirmation of every intermediate before the final release
- Library integrity (composition, representation) is measured, not assumed, before screening begins
- Expression constructs and validated expression data delivered with a complete conjugation or synthesis certificate
How the work runs
Library design
Diversity, degeneracy and deconvolution strategy for Peptide Drug Gene Construction and Expression Platform are fixed in a design document.
Library synthesis or construction
The library is built with gene synthesis and vector design and its composition is QC'd before screening.
Primary screening
Screening runs with expression construct optimization, with controls and statistics defined in advance.
Hit deconvolution
Hits are identified and ranked; counterscreens remove non-specific and promiscuous binders.
Hit confirmation
Every hit is resynthesized and re-tested; only reproducible hits advance.
Hit delivery
Confirmed hits and Expression constructs and validated expression data are delivered with the full screening data package.
Specifications & timeline
- Turnaround
- 4–8 weeks
- Typical scale
- 10^2 – 10^9 members by format
- Chemistry options
- gene synthesis and vector design; expression construct optimization; display-format compatibility
- Deliverable
- Expression constructs and validated expression data
- QC package
- Library composition QC, screening raw data, hit confirmation package
- Shipping
- Ambient (plates, beads) or dry ice (display libraries)
Related Products
- Recombinant ProteinsGrowth factors, cytokines and antigens produced across E. coli, yeast, insect and mammalian hosts — over 10,000 items on the shelf and ready to move.
- Native ProteinsIsolated directly from natural sources, preserving native post-translational modifications and conformational epitopes that recombinant systems can miss.
- Monoclonal AntibodiesRecombinant and hybridoma clones characterised for Western blot, IHC, immunofluorescence, ELISA and flow cytometry — application data included.
Next step
Tell us the target, we will tell you what is feasible
Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.